This page is the continuation of reference in support of Section 5d.
REFERENCES
Cayari, R., McGuire, L., Weinstein, S., Lakhani, S. (2010). Mucoepidermoid carcinoma of the breast. A case report and review of the literature. 42,81. (Retrieved November 14th 2014): https://journals.lww.com/pathologyrcpa/Fulltext/2010/42001/1
Cheson, B.D., Fisher, R.I., Barrington, S.F., et al. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J Clin Oncol 32(27), 3059-67. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979083/
Coyne, J.D., Dervan, P.A. (2002). Primary acinic cell carcinoma of the breast. Journal of Clinical Pathology 55(7), 545–547. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/12101208
Joks, M., Mysliwiec, K., Lewandowski, K. (2011). Primary breast lymphoma – a review of the literature and report of three cases. Arch Med Sci 7(1), 27-33. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258687/
Julen, O., Dellacasa, I., Pelte, M.F., Borish, B., Bouchardy, C., Capanna, F., Vlastos, G., Dubuisson, J.B., Vlastos, A.T. (2009). Primary breast lymphomas. Rare Tumors 1(1):e14. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994446/
Kellogg, B.C., Hiro, M.E., Payne, W.G. (2014). Implant-associated anaplastic large cell lymphoma: beyond breast prostheses. Ann Plast Surg 73(4), 461-4. (Retrieved November 12th 2014): https://www.ncbi.nlm.nih.gov/pubmed/23722577
Li, C.I., Uribe, D.J., Daling, J.R. (2005). Clinical characteristics of different histologic types of breast cancer. Br J Cancer 93(9),1046. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361680/
Nascimento, A.F., Raut, C.P., Fletcher, C.D. (2008). Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol 32(12), 1896-904. (Retrieved November 13th 2014): https://www.ncbi.nlm.nih.gov/pubmed/18813119
National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. (Retrieved November 6th 2014): http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T., Carbone, P.P. (1982).Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5, 649-655. (Retrieved November 14th 2014): http://www.ncbi.nlm.nih.gov/pubmed/7165009 http://www.npcrc.org/files/news/ECOG_performance_status.pdf
Rosen, P.P., Oberman, H. Tumors of the Mammary Gland, Armed Forces Institute of Pathology, Washington, DC 1993.
Sapino, A., Righi, L., Cassoni, P., Papotti, M., Pietribiasi, F., Bussolati, G. (2000). Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 17, 127–37. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/10839613
Silver, S.A., Tavassoli, F.A. (1998). Primary osteogeneic sarcoma of the breast. A clinicopathologic analysis of 50 cases. Am J Surg Pathol 22, 925-933. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/9706972
Vasudev, P., Onuma, K. (2011). Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med 135(12):1606-10. (Retrieved November 14th 2014): https://www.ncbi.nlm.nih.gov/pubmed/22129193
